Status:

UNKNOWN

Study to Assess Impact of Dietary Supplement on Sleep Health

Lead Sponsor:

Pharmanex

Collaborating Sponsors:

Dermatology Consulting Services, High Point NC

Conditions:

Sleep

Eligibility:

All Genders

20-60 years

Phase:

NA

Brief Summary

Sleep is essential for health and wellness. Sleep disruption can occur due to emotional stress, advancing age, hormonal imbalance, medications, and many other causes, some of which are presently unkno...

Eligibility Criteria

Inclusion

  • The subject is male or female 20-60 years of age at the time of informed consent.
  • Recorded baseline BMI is ≥18.5 and ≤29.9 kg/m2.
  • A score of 5 or higher on the Pittsburgh Sleep Quality Index.
  • Willing and able to give informed consent
  • Willing to maintain consistent diet and physical activity through the study period.
  • Willing to limit alcohol consumption to ≤14 drinks per week, no more than 4 drinks at a time, and no more than 1 drink within 4h of bedtime.
  • Willing to limit caffeine consumption to no more than 4 servings per day and no caffeine within 6h of bedtime.

Exclusion

  • Could not or did not want to participate in clinical study.
  • Taken nutritional supplements for sleep or stress in the previous 6 months.
  • Have received non-pharmacological treatment for sleep disorders (eg. Cognitive behavioral therapy, relation therapy) in previous 6 months
  • Any known allergy or intolerance to any of the ingredients contained in supplement.
  • Planned surgical procedure during the course of the study.
  • Used nicotine in the past 6 months.
  • Have a major psychiatric disorder as determined by the Mini International Neuropsychiatric Inventory
  • A history of unconventional sleep pattern, a diagnosed sleep disorder, or chronic medical condition that could affect energy/fatigue levels.
  • Consume more than 400mg of caffeine per day in the past 2 weeks.
  • Used any psychotropic medications, stimulants, cannabis, non-registered drug products, or illicit substances in the past 4 weeks.
  • At risk of drug or alcohol abuse
  • Used any sleep aids in the past 2 weeks.
  • Employed in night shift work or rotational shift work
  • Currently pregnant, nursing, planning to become pregnant, or unwilling to use a medically approved form of contraception will be excluded.
  • Individuals who sleep more than 10 hours.
  • Typically take a nap during the day.
  • Those planning travel or vacation during the study period.

Key Trial Info

Start Date :

August 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05971771

Start Date

August 1 2023

End Date

December 31 2023

Last Update

August 2 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.